Rituximab for the Treatment of Refractory Inflammatory Myopathies and Refractory Myasthenia Gravis
Clinical trial NCT00774462 · COMPLETED
Trial details
- NCT number
- NCT00774462
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-01-01
- Primary completion
- 2011-12-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.